COMMUNIQUÉS West-GlobeNewswire

Independent Readers Using Progenics’ PSMA AI Demonstrated a Statistically Significant Improvement of Accuracy, Speed, and Reproducibility Over Readers Without PSMA AI
24/06/2019
Oral Presentation of Progenics’ PSMA AI Technology at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2019 Annual Meeting NEW YORK, June 24, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ [...]
Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Highlight Unique Aspects of the Company’s GRAIN Technology Platform to Identify Novel Traits for Crops at the 3rd Precision CRISPR & NBT AgBio Congress
24/06/2019
WOBURN, Mass., June 24, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the agriculture and food [...]
Bariatric Medical Institute of Texas Presents Favorable Study Results for Obalon Balloon Administration Using Navigation Device and Touch Dispenser
24/06/2019
New clinical data highlight convenience, efficiency, and safety of Obalon’s proprietary Navigation and Touch Dispenser systems to achieve reliable balloon administration without the use of x-ray SAN DIEGO, June 24, 2019 [...]
Generex Investor Conference Call Recording Now Available Online Detailing 1:1 Stock Dividend, Merger for NuGenerex Immuno-Oncology and Go Forward Plans
24/06/2019
MIRAMAR, Fla., June 24, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today announced the audio recording of its investor [...]
Novelion Therapeutics Responds to Whitefort Capital Petition
24/06/2019
VANCOUVER, British Columbia, June 24, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare [...]
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2019 After Market Close on June 27, 2019
24/06/2019
TUSTIN, Calif., June 24, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by providing [...]
Celldex Therapeutics Appoints Diane C. Young, M.D. as Senior Vice President, Chief Medical Officer
24/06/2019
HAMPTON, N.J., June 24, 2019 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced the appointment of Diane C. Young, M.D., as Senior Vice President, Chief Medical Officer, effective July 8, 2019 [...]
Nationally Recognized Medical Experts Join Receptor Life Science’s Scientific Advisory Board to Guide the Development of New Cannabinoid Therapies
24/06/2019
SEATTLE, June 24, 2019 (GLOBE NEWSWIRE) -- Receptor Life Sciences (RLS), a leader in FDA-regulated cannabinoid medicine drug development using proprietary delivery technologies, today announced the formation of its [...]
electroCore Announces gammaCore(TM) Listing on the NHS Supply Chain Catalogue
24/06/2019
LONDON, and BASKING RIDGE, N.J., June 24, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that gammaCore TM , the company’s [...]
Krystal Biotech Announces Positive Results from Phase 2 Clinical Trial (“GEM-2 study”) of KB103 and Receives Regenerative Medicine Advanced Therapy (“RMAT”) Designation from FDA for KB103
24/06/2019
Safety data from all patients show that KB103 was well tolerated with no adverse events reported Five out of six wounds treated with KB103 in the Phase 2 trial closed 100% during the trial The average time to complete [...]
Dova Pharmaceuticals Announces Four Presentations on Avatrombopag in Patients with Chronic Immune Thrombocytopenia at the International Society on Thrombosis and Haemostasis (ISTH) 2019 Congress
24/06/2019
DURHAM, N.C., June 24, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) today announced the Company will present four abstracts with data from studies of avatrombopag in patients with chronic immune [...]
Medovex’s Transition to H-CYTE Underscores Biotechnology Focus
24/06/2019
Announces Long-Term Agreement to Launch a Promising New Cellular Treatment for COPD ALPHARETTA, Ga., June 24, 2019 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB: Symbol MDVX) ("Medovex" or the "Company"), is transitioning to [...]
BioDelivery Sciences Expands Upon Report from Pain Management Task Force
24/06/2019
Company’s Activities Support Buprenorphine Recommendations Including: Primary Use of Buprenorphine in Chronic Pain when Clinically Indicated Having Payers Provide Coverage and Reimbursement for Buprenorphine for Chronic [...]
Entasis Therapeutics Appoints David Meek as Chairman of the Board
24/06/2019
WALTHAM, Mass., June 24, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, [...]
Progenics Pharmaceuticals Files Supplemental Investor Presentation Rebutting Velan’s Latest Inaccurate Claims
24/06/2019
Board has Positioned Progenics to Maximize Value as a Result of Proactive and Deliberate Strategy Velan’s Baseless Criticisms about the Development of AZEDRA and 1095 Reveal a Fundamental Lack of Understanding of [...]
Blueberries Announces Appointment of Chief Financial Officer
24/06/2019
TORONTO, June 24, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. ( CSE: BBM ) (OTCQB: BBRRF) (FRA: 1OA) (" Blueberries " or the " Company "), a leading Latin American licensed producer of medicinal cannabis and [...]
Minerva Neurosciences Announces Achievement of Primary and Key Secondary Objectives in Phase 2b Clinical Trial of Seltorexant (MIN-202) in Insomnia
24/06/2019
Primary endpoint, defined as Latency to Persistent Sleep (LPS) at Night 1, showed improvement with a p-value ≤0.001 after treatment with 10 and 20 mg doses of seltorexant Key secondary endpoint, defined as Wake After [...]
Transactions under Novozymes’ stock buyback program
24/06/2019
Please read the full announcement in the attached PDF Attachment 2019_20_Stock_Buybackprogram_EN
Emerald Health Therapeutics reçoit un permis de culture pour une nouvelle exploitation de cannabis biologique en Colombie-Britannique
24/06/2019
Les installations biologiques se composent de 14 492 m² répartis sur deux serres et potentiellement de 9,7 ha de culture en plein air VANCOUVER, Colombie-Britannique, 24 juin 2019 (GLOBE NEWSWIRE) -- Emerald Health [...]

Pages